We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| WW International Inc | NASDAQ:WW | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.1601 | -12.13% | 1.1599 | 1.10 | 1.70 | 1.285 | 1.14 | 1.27 | 3,793,913 | 05:00:11 |
From Jul 2023 to Jul 2024
By Will Feuer
Shares of WW International, also known as WeightWatchers, fell after the pharmaceutical company Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new anti-obesity drug Zepbound.
The stock fell 12% to $6.77 in afternoon trading, the shares are up about 55% in the past 12 months.
WW has been pushing into telehealth in a bid to ride the wave of weight-loss drugs. Last year, the company bought telehealth firm Sequence for $106 million.
Analysts at DA Davidson said Lilly's telehealth platform, called LillyDirect, will likely have an advantage over rivals while supply of the weight-loss drugs is scarce. Once production ramps up, though, "the winners and losers in this space will be determined by who can provide the best service," the analysts said.
The new Lilly service also hit shares of other telehealth companies, including Hims & Hers Health, which traded down about 7%. Shares of LifeMD fell about 33%.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
January 04, 2024 16:15 ET (21:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
1 Year WW Chart |
1 Month WW Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
